Lantheus Holdings, Inc. (LNTH) News

Lantheus Holdings, Inc. (LNTH): $88.71

2.19 (-2.41%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Filter LNTH News Items

LNTH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

LNTH News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest LNTH News From Around the Web

Below are the latest news stories about LANTHEUS HOLDINGS INC that investors may wish to consider to help them evaluate LNTH as an investment opportunity.

Lantheus to buy Life Molecular Imaging for $350M and additional payment on earn-outs

More on Lantheus

Here’s What Lifted Lantheus Holdings (LNTH) in Q3

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The Fed’s rate cut in September contributed to a shift from large-cap generative AI winners to a broader range of market leadership, particularly in small-cap stocks. However, the strategy […]

Yahoo | January 7, 2025

Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices

Artificial intelligence is the watchword for investors, but some analysts also see strength this year in the medical sector. Lantheus Holdings is a standout among medical device makers, and its devices use artificial intelligence. Based on its strong fundamentals, Lantheus stock's Relative Strength (RS) Rating crossed above a milestone as it got upgraded from 80 to 83 Tuesday.

Yahoo | January 7, 2025

Lantheus Holdings, Inc. (LNTH): A Bull Case Theory

We came across a bullish thesis on Lantheus Holdings, Inc. (LNTH) on Value Investing Subreddit Page by Small_Bodybuilder_12. In this article, we will summarize the bulls’ thesis on LNTH. Lantheus Holdings, Inc. (LNTH)’s share was trading at $90.98 as of Dec 10th. LNTH’s trailing and forward P/E were 15.11 and 11.79 respectively according to Yahoo Finance. Lantheus […]

Yahoo | December 16, 2024

Is Weakness In Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

With its stock down 17% over the past month, it is easy to disregard Lantheus Holdings (NASDAQ:LNTH). However, a closer...

Yahoo | December 3, 2024

LNTH: Initiating Coverage - A Glowing Recommendation

By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT We are initiating coverage of Lantheus Holdings, Inc. (NASDAQ:LNTH) and assign a valuation of $134 per share. This valuation is based on our estimates for continued growth of Pylarify, Definity and TechneLite as well as long term opportunity in Alzheimer’s disease imaging and prostate cancer treatment among other strategic

Yahoo | December 3, 2024

Why Lantheus Holdings, Inc. (LNTH) Is One of the Most Profitable Pharmaceutical Stocks Right Now

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a look at where Lantheus Holdings, Inc. (NASDAQ:LNTH) stands against the other most profitable pharmaceutical stocks. The Pharmaceutical Industry: Growth, Innovation, and Emerging Challenges Healthcare, which includes numerous businesses that offer patient care, conduct […]

Yahoo | December 1, 2024

Lantheus Holdings’ (LNTH) Radiopharmaceutical Pipeline Fuels Growth Expectations

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. After experiencing losses in the second quarter, small-cap stocks notably increased in the third quarter. The Russell 2000 Growth Index (up 8.41%) underperformed the Russell 2000 […]

Yahoo | November 27, 2024

Why Lantheus Holdings Stock Won Big on Wednesday

The stock of radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) was a standout in the healthcare sector on Hump Day. The company saw its share price improve by almost 9% at market close, thanks to news of a shareholder-pleasing move. Well before market open, Lantheus announced the launch of a $250 million share repurchase program.

Yahoo | November 20, 2024

Lantheus Announces Share Repurchase Program

BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announces that its board of directors has authorized a program to repurchase up to $250 million of its common stock during the next twelve months. “With our strong financial position and the Board’s commitment to shareholder value, t

Yahoo | November 20, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!